Terms: = Head and neck cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717
156 results:
1. Sciellin promotes the development and progression of thyroid cancer through the jak2/STAT3 signaling pathway.
Guo H; Wang Z; Yin K; Ma R; Zhang Y; Yin F; Li H; Yin D
Mol Carcinog; 2024 Apr; 63(4):701-713. PubMed ID: 38411346
[TBL] [Abstract] [Full Text] [Related]
2. Cucurbitacin B Inhibits the Malignancy of Esophageal Carcinoma through the KIF20A/JAK/STAT3 Signaling Pathway.
Liu C; Ji J; Li C
Am J Chin Med; 2024; 52(1):275-289. PubMed ID: 38291583
[TBL] [Abstract] [Full Text] [Related]
3. AKT2
Chen J; Zhang L; Zhu Y; Zhao D; Zhang J; Zhu Y; Pang J; Xiao Y; Wu Q; Wang Y; Zhan Q
Signal Transduct Target Ther; 2024 Jan; 9(1):21. PubMed ID: 38280862
[TBL] [Abstract] [Full Text] [Related]
4. Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/jak2/STAT3 signaling axis.
Pradhan R; Paul S; Acharya SS; Sinha S; Dash SR; Kundu CN
J Nutr Biochem; 2024 Mar; 125():109568. PubMed ID: 38185347
[TBL] [Abstract] [Full Text] [Related]
5. G3BP1 Interact with jak2 mRNA to Promote the Malignant Progression of Nasopharyngeal Carcinoma via Activating jak2/STAT3 Signaling Pathway.
Zhan Y; Wang W; Wang H; Xu Y; Zhang Y; Ning Y; Zheng H; Luo J; Yang Y; Zang H; Zhou M; Fan S
Int J Biol Sci; 2024; 20(1):94-112. PubMed ID: 38164170
[TBL] [Abstract] [Full Text] [Related]
6. [Etiological analysis of a patient with multiple primary malignant neoplasms].
Shi PJ; Li YB; Xiao HP
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(47):3848-3851. PubMed ID: 38123227
[TBL] [Abstract] [Full Text] [Related]
7. Hsa_circ_0013561 promotes progression of nasopharyngeal carcinoma by activating jak2/STAT3 signaling pathway.
Kaisai T; Mantang Z; Tailei Y; Liying Z; Xiaoping C; Mingming J; Yi Z
Braz J Otorhinolaryngol; 2024; 90(1):101362. PubMed ID: 38006726
[TBL] [Abstract] [Full Text] [Related]
8. IL-6/jak2-dependent G6PD phosphorylation promotes nucleotide synthesis and supports tumor growth.
Qiu X; Ye H; Li X; Li D; Jiang L; Liu R; Zhao Z; He D
Mol Metab; 2023 Dec; 78():101836. PubMed ID: 37949355
[TBL] [Abstract] [Full Text] [Related]
9. The Experience of a Single Tertiary Center Regarding Benign and Malignant Tumors in Acromegalic Patients.
Plotuna IS; Balas M; Golu I; Amzar D; Vlad A; Moleriu LC; Vlad M
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374352
[No Abstract] [Full Text] [Related]
10. A PKM2 inhibitor induces apoptosis and autophagy through jak2 in human oral squamous cell carcinoma cells.
Weng JR; Gopula B; Chu PC; Hu JL; Feng CH
Chem Biol Interact; 2023 Aug; 380():110538. PubMed ID: 37164279
[TBL] [Abstract] [Full Text] [Related]
11. FOXK1 regulates epithelial-mesenchymal transition and radiation sensitivity in nasopharyngeal carcinoma via the JAK/STAT3 signaling pathway.
Duan L; Huang J; Zhang Y; Pi G; Ying X; Zeng F; Hu D; Ma J
Genes Genomics; 2023 Jun; 45(6):749-761. PubMed ID: 37043129
[TBL] [Abstract] [Full Text] [Related]
12. Effects of Arctigenin in Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma 5-8F Cells.
Huang D; Lu R; Cai M; Meng J; He S; Zhang Q; Meng W
Anticancer Agents Med Chem; 2023; 23(10):1211-1216. PubMed ID: 36852795
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
Hong L; Aminu M; Li S; Lu X; Petranovic M; Saad MB; Chen P; Qin K; Varghese S; Rinsurongkawong W; Rinsurongkawong V; Spelman A; Elamin YY; Negrao MV; Skoulidis F; Gay CM; Cascone T; Gandhi SJ; Lin SH; Lee PP; Carter BW; Wu CC; Antonoff MB; Sepesi B; Lewis J; Gibbons DL; Vaporciyan AA; Le X; Jack Lee J; Roy-Chowdhuri S; Routbort MJ; Gainor JF; Heymach JV; Lou Y; Wu J; Zhang J; Vokes NI
Nat Commun; 2023 Feb; 14(1):695. PubMed ID: 36755027
[TBL] [Abstract] [Full Text] [Related]
14. Circ_0000052/miR-382-3p axis induces PD-L1 expression and regulates cell proliferation and immune evasion in head and neck squamous cell carcinoma.
Zhang DJ; Fu ZM; Guo YY; Guo F; Wan YN; Guan GF
J Cell Mol Med; 2023 Jan; 27(1):113-126. PubMed ID: 36515567
[TBL] [Abstract] [Full Text] [Related]
15. IL-33/ST2 signaling promotes constitutive and inductive PD-L1 expression and immune escape in oral squamous cell carcinoma.
Zhao M; He Y; Zhu N; Song Y; Hu Q; Wang Z; Ni Y; Ding L
Br J Cancer; 2023 Mar; 128(5):833-843. PubMed ID: 36463324
[TBL] [Abstract] [Full Text] [Related]
16. Somatic 9p24.1 alterations in HPV
Zhao X; Cohen EEW; William WN; Bianchi JJ; Abraham JP; Magee D; Spetzler DB; Gutkind JS; Alexandrov LB; Cavenee WK; Lippman SM; Davoli T
Proc Natl Acad Sci U S A; 2022 Nov; 119(47):e2213835119. PubMed ID: 36395141
[TBL] [Abstract] [Full Text] [Related]
17. Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasia.
Gan CP; Lee BKB; Lau SH; Kallarakkal TG; Zaini ZM; Lye BKW; Zain RB; Sathasivam HP; Yeong JPS; Savelyeva N; Thomas G; Ottensmeier CH; Ariffin H; Cheong SC; Lim KP
Front Immunol; 2022; 13():954567. PubMed ID: 36119104
[TBL] [Abstract] [Full Text] [Related]
18. Pharmacogenomic landscape of head and neck squamous cell carcinoma informs precision oncology therapy.
Gu Z; Yao Y; Yang G; Zhu G; Tian Z; Wang R; Wu Q; Wang Y; Wu Y; Chen L; Wang C; Gao J; Kang X; Zhang J; Wang L; Duan S; Zhao Z; Zhang Z; Sun S
Sci Transl Med; 2022 Sep; 14(661):eabo5987. PubMed ID: 36070368
[TBL] [Abstract] [Full Text] [Related]
19. cancer-associated fibroblast-like fibroblasts in vocal fold leukoplakia suppress CD8
Fang Y; Chen M; Li G; Yang Y; He P; Chen J; Cheng L; Wu H
Cancer Lett; 2022 Oct; 546():215839. PubMed ID: 35961512
[TBL] [Abstract] [Full Text] [Related]
20. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating jak2/STAT3 signaling.
Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B
Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296
[TBL] [Abstract] [Full Text] [Related]
[Next]
